908 Devices Inc.
MASS- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001555279
In the last 90 days, 908 Devices Inc. insiders filed 0 open-market purchases and 10 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $244.1M in total; ARK Invest is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:30 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net income for FY2025: $19.5M (34.7% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 20, 2026 | Mar 4, 2025 | Mar 5, 2024 | Mar 7, 2023 | Jan 10, 2022 |
| Revenue | $56.2M | $59.6M | $50.2M | $46.9M | $42.2M |
| Cost of revenue | $27.8M | $29.8M | $24.9M | $20.8M | $19.0M |
| Gross profit | $28.4M | $29.9M | $25.3M | $26.0M | $23.2M |
| Operating expenses | $67.8M | $106.6M | $68.1M | $61.4M | $45.3M |
| Research and development | $15.6M | $25.5M | $21.9M | $17.5M | $13.1M |
| Selling, general and administrative | $38.5M | $53.6M | $46.2M | $43.9M | $32.2M |
| Operating income | -$39.4M | -$76.7M | -$42.8M | -$35.4M | -$22.1M |
| Interest expense | – | – | $201.0K | $129.0K | $486.0K |
| Income tax | -$66.0K | -$282.0K | -$211.0K | – | – |
| Net income | $19.5M | -$72.2M | -$36.4M | -$33.6M | -$22.2M |
| EPS, basic | $0.54 | $-2.12 | $-1.13 | $-1.07 | $-0.79 |
| EPS, diluted | $0.54 | $-2.12 | $-1.13 | $-1.07 | $-0.79 |
| Weighted shares, basic | 35.9M | 34.1M | 32.2M | 31.5M | 28.0M |
| Weighted shares, diluted | 35.9M | 34.1M | 32.2M | 31.5M | 28.0M |
| Margins and growth | |||||
| Gross margin | 50.6% | 50.1% | 50.4% | 55.5% | 55.0% |
| Operating margin | -70.1% | -128.7% | -85.1% | -75.5% | -52.3% |
| Net margin | 34.7% | -121.1% | -72.5% | -71.6% | -52.5% |
| Revenue growth, year over year | −5.8% | +18.7% | +7.2% | +11.0% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 20, 2026 | Mar 4, 2025 | Mar 5, 2024 | Mar 7, 2023 | Jan 10, 2022 |
| Cash and equivalents | $70.5M | $44.0M | $121.0M | $188.4M | $224.1M |
| Short-term investments | $42.5M | $25.6M | $24.6M | – | – |
| Accounts receivable | $11.3M | $12.6M | $8.99M | $10.0M | $16.4M |
| Inventory | $13.0M | $16.2M | $14.9M | $12.5M | $7.92M |
| Total current assets | $144.6M | $103.1M | $173.8M | $215.6M | $252.9M |
| Property, plant and equipment | $4.23M | $3.42M | $3.34M | $3.08M | $1.60M |
| Goodwill | $0 | $0 | $10.4M | $10.1M | – |
| Intangible assets | $36.4M | $45.3M | $7.86M | $8.49M | – |
| Total assets | $190.1M | $159.5M | $203.0M | $242.6M | $260.9M |
| Accounts payable | $1.59M | $2.06M | $1.19M | $1.40M | $1.37M |
| Total current liabilities | $34.1M | $25.1M | $22.5M | $19.2M | $14.8M |
| Long-term debt | – | – | – | $15.0M | $15.0M |
| Total liabilities | $46.4M | $44.9M | $37.5M | $52.0M | $46.3M |
| Shareholders' equity | $143.7M | $114.6M | $165.5M | $190.6M | $214.6M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 20, 2026 | Mar 4, 2025 | Mar 5, 2024 | Mar 7, 2023 | Jan 10, 2022 |
| Operating cash flow | -$23.7M | -$30.2M | -$25.1M | -$20.9M | -$29.1M |
| Capital expenditures | $955.0K | $602.0K | $2.04M | $2.04M | $737.0K |
| Free cash flow | -$24.6M | -$30.8M | -$27.1M | -$23.0M | -$29.8M |
| Depreciation and amortization | $4.46M | $4.68M | $2.38M | $1.61M | $925.0K |
| Stock-based compensation | $9.85M | $11.8M | $9.79M | $7.21M | $2.50M |
| Investing cash flow | $50.7M | -$46.3M | -$26.4M | -$15.8M | -$737.0K |
| Financing cash flow | -$697.0K | -$376.0K | -$15.9M | $1.18M | $94.7M |
| Net change in cash | $26.4M | -$77.0M | -$67.4M | -$35.5M | $64.9M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 17.5% | 19.7% | 19.5% | 15.4% | 5.9% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.